Isoguvacine

Isoguvacine

SCHEMBL339700

O=C(O)C1=CCNCC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoguvacine SCHEMBL6214170 0.98 TSHR (0.96)
Isoguvacine SCHEMBL7958625 0.98 BLM (1.00)
Isoguvacine SCHEMBL15260680 0.96 TSHR (0.92)
SCHEMBL9568927 0.84 TSHR (0.72)
SCHEMBL29439268 0.80 TSHR (0.67)
SCHEMBL2032868 0.80
SCHEMBL9497437 0.80
Hydrochloric Acid SCHEMBL14311854 0.78 BLM (0.68)
Hydrochloric Acid SCHEMBL5249049 0.78 BLM (0.68)
SCHEMBL29439332 0.77 GABRR1 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250319110-A1 SURFACE CALR CHEMICAL INDUCERS ZON LEONARD (US) 2025-10-16 US claimed
CN-120025976-A Method for differentiating hematopoietic stem/progenitor cells into granulocytes 苏州血霁生物科技有限公司 2025-05-23 CN claimed
US-20250163379-A1 METHOD FOR DIFFERENTIATING HEMATOPOIETIC STEM/PROGENITOR CELLS INTO NK CELLS HEMACELL BIOTECHNOLOGY INC. (CN) 2025-05-22 US claimed
WO-2025085689-A1 EXTRACELLULAR SMALL MOLECULE ACTIVATORS TARGETING BESTROPHIN CHANNELS FOR DISEASE TREATMENT THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2025-04-24 WO claimed
EP-4540374-A1 SURFACE CALR CHEMICAL INDUCERS The Children's Medical Center Corporation (US) 2025-04-23 EP claimed
WO-2025024501-A1 NEUROMODULATORY PEPTIDES LACTOCORE, INC. (US) 2025-01-30 WO claimed
US-12201631-B2 Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and fragile X syndrome PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-01-21 US claimed
US-12161695-B2 GABA A receptor agonists for treatment of disorders influenced by dysfunction BETA cells DIAMYD MEDICAL AB (SE) 2024-12-10 US claimed
US-20240390311-A1 COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS RELATING TO CORONAVIRUS INFECTIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-11-28 US claimed
CN-118786209-A Method for differentiating hematopoietic stem/progenitor cells into NK cells 苏州血霁生物科技有限公司 2024-10-15 CN claimed
EP-0840601-A1 NON-ALLOSTERIC GABA-A AGONISTS FOR TREATING SLEEP DISORDERS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1998-05-13 EP claimed
EP-0789567-A1 A METHOD FOR TREATING VASCULAR HEADACHES THE GENERAL HOSPITAL CORPORATION (US) 1997-08-20 EP claimed
WO-1997002813-A1 NON-ALLOSTERIC GABAA AGONISTS FOR TREATING SLEEP DISORDERS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1997-01-30 WO claimed
US-5587509-A Caged caboxyl compounds and use thereof CORNELL RESEARCH FOUNDATION, INC. (US) 1996-12-24 US claimed
CN-1130059-A Use of an agonisl substances of a receptors associated with a chlorine channel in the treatment of wrinkles OREAL (FR) 1996-09-04 CN claimed
WO-1996015782-A1 A METHOD FOR TREATING VASCULAR HEADACHES THE GENERAL HOSPITAL CORPORATION (US) 1996-05-30 WO claimed
US-5430175-A Caged carboxyl compounds and use thereof CORNELL RESEARCH FOUNDATION, INC. (US) 1995-07-04 US claimed
WO-1995015305-A1 CAGED CARVOXYL COMPOUNDS AND THEIR USE IN CHEMICAL KINETIC INVESTIGATION OF NEUROTRANSMITTER RECEPTORS CORNELL RESEARCH FOUNDATION, INC. (US) 1995-06-08 WO claimed
EP-0537993-A1 Nicotinic activity of a series of arecolones and isoarecolones ELI LILLY AND COMPANY (US) 1993-04-21 EP claimed
EP-0000167-A1 1,2,3,6-Tetrahydroisonicotinic acid and derivatives thereof, methods and starting products for their preparation, and pharmaceutical compositions containing them. Krogsgaard-Larsen, Povl (DK) 1979-01-10 EP claimed